biotech – Page 3

GSK Advances Liver Disease Research and Biotech CEO Sisterhood Grows Influence

7 months ago talkbio0Tagged biotech, CEO, Drug Industry, JPM25, Liver diseases, sisterhood, SmithKline Beecham, Women

GSK, liver disease, Biotech CEO Sisterhood, JPM25, pharmaceutical industry, women in biotech

Tune Therapeutics Secures $175M in Series B Funding to Advance Epigenome Editing Programs

7 months ago talkbio0Tagged biotech, Epigenome, gene therapy, Hepatitis B treatment, Investments, Series B, Tune

Epigenome editing, Tune Therapeutics, Series B funding, Hepatitis B treatment, Gene therapy, Biotech investment

Leyden Labs Secures $70 Million Funding to Develop Broad Protection Against Respiratory Viruses

8 months ago talkbio0Tagged biotech, Laboratory test finding, Leyden, Mucosal Protection Platform, Nasal, Nasal defenses, PanFlu, Protection, Respiratory viruses

Leyden Labs, Respiratory viruses, Influenza, Nasal defenses, Broad protection, PanFlu, Mucosal Protection Platform, Biotech funding

Novo Nordisk and Valo Health Expand AI-Driven Collaboration to Develop Novel Treatments for Obesity, Type 2 Diabetes, and Cardiovascular Disease

8 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, biotech, Cardiovascular Diseases, Computational Technique, Diabetes, Drug Development, Nordisk, Obesity, Valo Health

Novo Nordisk, Valo Health, AI, Obesity, Type 2 Diabetes, Cardiovascular Disease, Drug Development, Computational Biotech

Roche’s Chugai Enters $780M Deal with Swiss ADC Specialist Araris Biotech

8 months ago talkbio0Tagged Antibody-Drug Conjugates, Araris, biotech, Chugai, Roche (company), therapeutic autologous dendritic cells

Roche, Chugai, Araris Biotech, ADC, Antibody-Drug Conjugate, Biotech Deal

Orbis Kicks Off 2025 with €90M Series A Funding in Fierce Biotech Fundraising Tracker

8 months ago talkbio0Tagged biotech, Biotech Fundraising Tracker, Biotech Investments, Capital, Fierce, Funding, funding rounds, Orbis, Series, venture

Fierce Biotech Fundraising Tracker 2025, Orbis Series A Funding, Biotech Venture Capital, 2025 Biotech Investments, Series A Funding Rounds

I-Mab Shifts Focus Away from CD73 Program to Pursue Strategic Options in CLDN18.2 Space

8 months ago talkbio0Tagged 5'-NUCLEOTIDASE, biotech, development aspects, I-Mab, sanofi, Strategic Options

I-Mab, CD73, CLDN18.2, Sanofi, Strategic Options, Biotech Development

Regeneron Expands Ophthalmology Portfolio with Acquisition of UK-Based Biotech Oxular

8 months ago talkbio0Tagged Acquisition, biotech, Drug Delivery Systems, Ophthalmology specialty, Oxular, Regeneron, Retinal Diseases, Technology

Regeneron, Oxular, Biotech Acquisition, Ophthalmology, Retinal Disorders, Drug Delivery Technology

Acelyrin Reassesses Flagship Immunology Asset Izokibep Following Multiple Clinical Trial Setbacks

9 months ago talkbio0Tagged Acelyrin, Arthritis, Psoriatic, biotech, Clinical Trials, Failure (biologic function), Hidradenitis, Immunology, IPO, Izokibep, suppurativa

Acelyrin, Izokibep, Clinical Trial Failure, Immunology, Hidradenitis Suppurativa, Psoriatic Arthritis, Biotech IPO

From Partnership to Acquisition: The $1.5 Billion Journey of Roche and Poseida Therapeutics

9 months ago talkbio0Tagged Acquisition, allogeneic cell therapy, biotech, CAR-T, Drug Industry, Genetic, genetic medicines, Poseida Therapeutics/ Inc., Roche (company)

Roche Holdings/ Inc., Poseida Therapeutics/ Inc., Allogeneic cell therapy, CAR-T programs, Genetic medicines, Biotech acquisition, Pharmaceutical industry